Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

05 janv. 2024 07h09 HE | Source: KuicK Research

Cancer Antibodies Combination Therapies Clinical Research Market Size Insight

Delhi, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Global Cancer Antibody Combinations Market Opportunity & Clinical Trials Insight 2028 Report Findings & Highlights: Global Cancer Antibody...
09 juin 2022 07h19 HE | Source: KuicK Research

Combination Cancer Therapy Clinical Trials Therapies Research Report 2028

Singapore, June 09, 2022 (GLOBE NEWSWIRE) -- Global Combination Cancer Immunotherapy Market Opportunity & Clinical Trials Insight 2028 Report Highlights: Global & Regional Combination...
09 juin 2022 05h42 HE | Source: KuicK Research

Combination Cancer Therapy Market Insight 2028

Singapore, June 09, 2022 (GLOBE NEWSWIRE) -- Global Combination Cancer Immunotherapy Market Opportunity & Clinical Trials Insight 2028 Report Highlights: Global & Regional Combination...
09 juin 2020 09h00 HE | Source: Provectus Biopharmaceuticals Inc.

Provectus Biopharmaceuticals Expands Global Patent Portfolio to India for Cancer Combination Therapy

2020 India patent follows 2018 India patent that protects Provectus’ proprietary API manufacturing processProvectus further expands cancer combination therapy IP protection by filing new USPTO patent...
18 avr. 2018 06h00 HE | Source: Provectus Biopharmaceuticals Inc.

PROVECTUS BIOPHARMACEUTICALS EXPANDS GLOBAL PATENT PORTFOLIO FOR CANCER COMBINATION THERAPY

FOR IMMEDIATE RELEASE KNOXVILLE, TN, April 18, 2018 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, www.provectusbio.com) (“Provectus” or the “Company”), a clinical-stage...